Deutsche Bank Callable Leveraged Steepener Notes (Cusip: 25152RYF4)

Did You Invest in Deutsche Bank Callable Leveraged Steepener Notes (Cusip:25152RYF4), due March 27, 2035, Based on the Spread between the 30-Year CMS Rate and the 2-Year CMS Rate?

According to Deutsche Bank Callable Leveraged Steepener Notes (Cusip:25152RYF4):

By acquiring the notes, you will be bound by, and deemed to consent to, the imposition of any Resolution Measure (as defined below) by our competent resolution authority, which may include the write down of all, or a portion, of any payment on the notes. If any Resolution Measure becomes applicable to us, you may lose some or all of your investment in the notes. Please see “Resolution Measures” on page 4 of this term sheet for more information.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this term sheet or the accompanying prospectus supplement, prospectus or prospectus addendum. Any representation to the contrary is a criminal offense.

Investors ought to be cautious with this type of investment. According to the Financial Industry Regulatory Authority (FINRA):

If you bought the structured product known as Deutsche Bank Callable Leveraged Steepener Notes (Cusip:25152RYF4), due March 27, 2035, Based on the Spread between the 30-Year CMS Rate and the 2-Year CMS Rate, and it was sold to you as a safe, liquid, and/or conservative investment, and then you suffered losses, you may have a claim. Contact the attorneys at Sonn Law Group for free consultation.

Image credit: Elliot Brown via Flickr